4
Changes in Ownership
Roivant Sciences Ltd. Filed Acc 0001140361-25-005053
Chief Accounting Officer sold 227,500 shares at $10.43 ($2,372,825)
- Chief Accounting Officer acquired 187,500 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Kumar Rakhi Chief Accounting Officer | 2025-02-13 | Option exercise | +187,500 | $3.85 | $721,875 | 390,764 | D: show line 1 in the form |
| Kumar Rakhi Chief Accounting Officer | 2025-02-13 | Sale | −227,500 | $10.43 | $2,372,825 | 163,264 | D: show line 2 in the form |
| Open-market sales · 227,500 sh · avg $10.43 · $2,372,825 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Kumar Rakhi Chief Accounting Officer | 2025-02-13 | Option exercise · Stock Option (Right to Buy) | −187,500 | 312,500 | D: show line 3 in the form |
Loading xslF345X05/form4.xml…